Japan Digestive Disease Week 2016
International Poster Session(JDDW)
November 4 (Fri.), 15:04–15:44, Room 16 (Kobe International Exhibition Hall No. 2 Building Hall (North) Digital Poster Session)
IP-57_H
Usefulness of Albumin-Bilirubin-based Japan Integrated Staging (ALBI-T) score among Chinese patients with hepatocellular carcinoma
- 1
- Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong
- 2
- Department of Chemical Pathology, The Chinese University of Hong Kong
- 3
- Department of Surgery, The Chinese University of Hong Kong
- 4
- Department of Clinical Oncology, The Chinese University of Hong Kong
Background
Japan Integrated Staging(JIS) for hepatocellular carcinoma(HCC) has been extensively studied in hepatitis virus C-endemic Japanese population but seldom evaluated outside Japan, while Albumin-Bilirubin (ALBI)-based JIS(ALBI-T) has never been externally validated.
Methods
A cohort of 1973 Chinese patients with HCC was employed to evaluate the prognostic performance of JIS and ALBI-T scores by homogeneity likelihood chi-square, Harrell's c-index and corrected Akaike information criterion(AICc).
Results
The ALBI-T score showed better prognostic performance than the JIS score, which were indicated by homogeneity likelihood chi-squares (ALBI-T 813.57 vs. JIS 781.94), c-indices (ALBI-T 0.74 vs. JIS 0.73) and AICs (ALBI-T 16573.51 vs. JIS 16605.15).
Conclusions
The ALBI-T score is applicable to Chinese patients to provide good prognostic information.
Japan Integrated Staging(JIS) for hepatocellular carcinoma(HCC) has been extensively studied in hepatitis virus C-endemic Japanese population but seldom evaluated outside Japan, while Albumin-Bilirubin (ALBI)-based JIS(ALBI-T) has never been externally validated.
Methods
A cohort of 1973 Chinese patients with HCC was employed to evaluate the prognostic performance of JIS and ALBI-T scores by homogeneity likelihood chi-square, Harrell's c-index and corrected Akaike information criterion(AICc).
Results
The ALBI-T score showed better prognostic performance than the JIS score, which were indicated by homogeneity likelihood chi-squares (ALBI-T 813.57 vs. JIS 781.94), c-indices (ALBI-T 0.74 vs. JIS 0.73) and AICs (ALBI-T 16573.51 vs. JIS 16605.15).
Conclusions
The ALBI-T score is applicable to Chinese patients to provide good prognostic information.
As no diagrams are provided here, please refer to each academic journal of structure and member societies.
- Index Term 1: hepatocellular carcinoma
- Index Term 2: tumor staging